We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLPR
3026
Clipper Realty
CLPR
$52.5M
$4.74K ﹤0.01%
1,313
– –
AFRI icon
3027
Forafric Global
AFRI
$289M
$4.6K ﹤0.01%
431
– –
PRPL icon
3028
Purple Innovation
PRPL
$29.2M
$4.59K ﹤0.01%
177
– –
PBE icon
3029
Invesco Biotechnology & Genome ETF
PBE
$358M
$4.54K ﹤0.01%
70
– –
SWKH
3030
DELISTED
SWK Holdings
SWKH
$4.54K ﹤0.01%
337
– –
OPAD icon
3031
Offerpad Solutions
OPAD
$22.3M
$4.52K ﹤0.01%
+102
New +$6.33K
GALT icon
3032
Galectin Therapeutics
GALT
$341M
$4.51K ﹤0.01%
+1,995
New +$6.06K
OTLK icon
3033
Outlook Therapeutics
OTLK
$160M
$4.48K ﹤0.01%
607
– –
VCSA
3034
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$4.47K ﹤0.01%
+918
New +$5.06K
PROP icon
3035
Prairie Operating Co
PROP
$83.8M
$4.45K ﹤0.01%
+410
New +$5.19K
TPIF icon
3036
Timothy Plan International ETF
TPIF
$266M
$4.3K ﹤0.01%
162
– –
IYM icon
3037
iShares US Basic Materials ETF
IYM
$1.01B
$4.2K ﹤0.01%
30
– –
XAR icon
3038
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.61B
$4.2K ﹤0.01%
30
– –
IBB icon
3039
iShares Biotechnology ETF
IBB
$9.79B
$4.12K ﹤0.01%
30
– –
AEVA
3040
Aeva Technologies
AEVA
$1.64B
$4.12K ﹤0.01%
1,633
– –
SIRI icon
3041
SiriusXM
SIRI
$9.47B
$4.1K ﹤0.01%
145
-11,135
-99% -$333K
ITA icon
3042
iShares US Aerospace & Defense ETF
ITA
$14.9B
$4.09K ﹤0.01%
31
– –
ACRV icon
3043
Acrivon Therapeutics
ACRV
$78.3M
$4.03K ﹤0.01%
695
– –
PBW icon
3044
Invesco WilderHill Clean Energy ETF
PBW
$461M
$3.97K ﹤0.01%
197
– –
GPGI
3045
GPGI Inc
GPGI
$3.85B
$3.96K ﹤0.01%
702
– –
VALU icon
3046
Value Line
VALU
$366M
$3.92K ﹤0.01%
91
– –
GCTS
3047
GCT Semiconductor Holding
GCTS
$203M
$3.87K ﹤0.01%
+742
New +$4.16K
ISMD icon
3048
Inspire Small/Mid Cap Impact ETF
ISMD
$346M
$3.8K ﹤0.01%
110
-60
-35% -$2.08K
OVID icon
3049
Ovid Therapeutics
OVID
$517M
$3.79K ﹤0.01%
4,924
– –
TPHD icon
3050
Timothy Plan High Dividend Stock ETF
TPHD
$370M
$3.68K ﹤0.01%
105
-50
-32% -$1.76K
120 121
122
123 124

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.2B AUM 32.2% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.